FDA Investigator James I Vik
James I Vik has conducted inspections on 421 sites in 4 countries as of 27 Nov 2012. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
421
Last Inspection Date:
27 Nov 2012
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Thailand,
Venezuela (Bolivarian Republic of),
Brazil
FDA Investigators that have inspected at least one site in common with James I Vik:
Aaron J Poloni,
Abby M Miller,
Alexander M Kay,
Ava M Bowman,
Avery J Dennis,
Belinda E Clifton,
Bradley J Maunder,
Brenda K Alford,
Brittany R Laymon,
Bruce R Burrell,
Bryce E Mansfield,
Camille Bennett Hoffman,
Catherine J Laufmann,
Celia L Hutchinstein,
Celia L Silverstein,
Christopher E Rezendes,
Connie P Rezendes,
Crystal A Harlan,
Daniel A Congdon,
David P Moorhead,
Dawn E Barkans,
Deborah A Nebenzahl,
Debra D Devlieger,
Dennis R Hudson,
Devon M Shoop,
Dirk L Lincoln,
Donald B Mckechnie,
Elizabeth A Sheller,
Elizabeth S Howell,
Eric C Milstead,
Eric L Scott,
Eric S Myskowski,
Gerard Pde Leon,
Gregory A Holt,
Hanna L Potter,
Harmon M Blanch,
Hugh A Grimoldby,
James D Hildreth,
James E Trabert,
Jason W Cornell,
Jean Brewer,
Jeanne M Weishaar,
Jeffrey N Gerdes,
Jennifer M Pouget,
Jessica B Clark,
Jessica L Kocian,
Jim I Vik,
Jinkee Mvila Binayug,
John E Emmert,
Jonathan T Little,
Joseph M Hudak,
Joseph T Dougherty,
Julia E Chervoni,
Julie A Stocklin,
Katherine L Arnold,
Kathryn M Mogen,
Kenneth O Gee, PhD,
Kevin T Gerrity,
Lance W Bohm,
Lesley A Swanson,
Lisa A Bowden,
Lisa K Capron,
Marcus A Goshen,
Margo C Jones,
Mark E Imsland,
Mark E Moen,
Mark L Collins,
Marsha L Mccauley,
Mary M Finn,
Matthew B Thomaston,
Michael J Donovan,
Mikel T Wright,
Nancy E Byerly,
Nancy E Doyle,
Orval D Mcintire,
Othello G Capangpangan,
Patrick J Campbell,
Paul F Rader,
Paula J Wilkerson,
Peter T Regan,
Phal K Chhun,
Randy L Elsberry,
Rebecca T Davis,
Rita E Luttrell,
Ronald E Gill,
Scott W Fox,
Shannon J Hall,
Sharon I Gundersen,
Sharon K Ferguson,
Shelagh D Schopen,
Sunny R Muir,
Thomas C Mclean, CFS,
Victor A Meo,
Wayne F Larson,
William C Hughes,
William G Nelson,
Young M Yoon
James I Vik's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2002 | FDA 483 | Earth & Plant Inc. - Form 483, 2002-05-30 |
November, 2002 | FDA 483 | Sagaya Corporation - Form 483, 2002-11-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more